<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC 2022 17_9-10_166</article-id>
<article-id pub-id-type="doi">10.15836/ccar2022.166</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
<subj-group subj-group-type="subheading"><subject>Acute coronary syndromes</subject></subj-group>
</article-categories>
<title-group>
<article-title>Modifiable risk factors for heart disease and coronary flow reserve assessed by transthoracic echocardiography</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5374-0892</contrib-id><name><surname>Begi&#x0107;</surname><given-names>Alden</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6842-262X</contrib-id><name><surname>Begi&#x0107;</surname><given-names>Edin</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3749-6073</contrib-id><name><surname>&#x0160;abanovi&#x0107;-Bajramovi&#x0107;</surname><given-names>Nirvana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4677-8489</contrib-id><name><surname>Iglica</surname><given-names>Amer</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6228-6230</contrib-id><name><surname>Granov</surname><given-names>Nermir</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7309-1455</contrib-id><name><surname>Dili&#x0107;</surname><given-names>Mirza</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1863-5755</contrib-id><name><surname>Begi&#x0107;</surname><given-names>Zijo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<aff id="aff1"><label>1</label>Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina</aff>
<aff id="aff2"><label>2</label>General Hospital &#x201C;Prim.dr. Abdulah Naka&#x0161;&#x201D;, Sarajevo, Bosnia and Herzegovina</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Alden Begi&#x0107;, Klini&#x010D;ki centar Univerziteta Sarajevo, Bolni&#x010D;ka 25, 71000 Sarajevo, Bosnia and Herzegovina. / Phone: +387-61-203-300 / E-mail: <email xlink:href="aldenbegic@yahoo.com">aldenbegic@yahoo.com</email></corresp></author-notes>
<pub-date pub-type="epub-ppub"><month>11</month><year>2022</year></pub-date>
<volume>17</volume>
<issue>9-10</issue>
<fpage>166</fpage>
<lpage>166</lpage>
<history>
<date date-type="received"><day>04</day><month>11</month><year>2022</year></date>
<date date-type="accepted"><day>10</day><month>11</month><year>2022</year></date>
</history>
<permissions>
<copyright-year>2022</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>KEYWORDS: </title><kwd>echocardiography</kwd><kwd>atherosclerosis</kwd><kwd>prevention</kwd></kwd-group>
</article-meta>
</front>
<body>
<p><bold>Goal:</bold> To indicate the influence of risk factors for the development of coronary artery disease (CAD) on coronary flow reserve (CFR) values assessed by transthoracic echocardiography (TTE) &#x200B;&#x200B;in patients without verified CAD.</p>
<p><bold>Methods:</bold> The paper presents an analysis of the available literature from reference databases covering the mentioned topic.</p>
<p><bold>Results:</bold> TTE-CFR presents a ratio of hyperaemic coronary blood flow during maximum vasodilation in relation to resting coronary blood flow. The most commonly used vasodilators are dipyridamole and adenosine (adenosine 140 mcg&#x2044;kg&#x2044;min (1-2 min), dipyridamole 0.84 mg&#x2044;kg&#x2044;6 min). Age and female gender have a lesser effect on the values of hyperemic CFR. Ethnic differences (vascularization, left ventricle structure) can influence the CFR values. Also, obesity, smoking, hyperlipidemia, elevated values &#x200B;&#x200B;of low-density lipoproteins (LDL), arterial hypertension, diabetes mellitus, and obstructive sleep apnea in a healthy population can have a negative effect on CFR values.</p>
<p><bold>Conclusion:</bold> There is evidence of the effect of risk factors for CAD on CFR values &#x200B;&#x200B;in a population without established pathology. (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>-<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>) It is a marker of the early stages of coronary atherosclerosis (a tool in the stratification of patients regarding cardiovascular risk, and it could be a guide in the primary prevention of cardiovascular disease). Also, TTE-CFR&lt;2 has good sensitivity and specificity to predict the significance of stenosis. Clinical presentation of the patient should be a part of the mosaic of interpretation of test results. CFR is an additional test, and stress echocardiography presents the first choice in the evaluation of ischemic heart disease.</p>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciampi</surname><given-names>Q</given-names></name><name><surname>Zagatina</surname><given-names>A</given-names></name><name><surname>Cortigiani</surname><given-names>L</given-names></name><name><surname>Gaibazzi</surname><given-names>N</given-names></name><name><surname>Borguezan Daros</surname><given-names>C</given-names></name><name><surname>Zhuravskaya</surname><given-names>N</given-names></name><etal/></person-group> <article-title>Stress Echo 2020 Study Group of the Italian Society of Echocardiography and Cardiovascular Imaging. Functional, Anatomical, and Prognostic Correlates of Coronary Flow Velocity Reserve During Stress Echocardiography.</article-title> <source>J Am Coll Cardiol</source>. <year>2019</year>;<volume>74</volume>(<issue>18</issue>):<fpage>2278</fpage>&#x2013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2019.08.1046</pub-id><pub-id pub-id-type="pmid">31672185</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rigo</surname><given-names>F</given-names></name></person-group>. <article-title>Coronary flow reserve in stress-echo lab. From pathophysiologic toy to diagnostic tool.</article-title> <source>Cardiovasc Ultrasound</source>. <year>2005</year> March 25;<volume>3</volume>:<fpage>8</fpage>. <pub-id pub-id-type="doi">10.1186/1476-7120-3-8</pub-id><pub-id pub-id-type="pmid">15792499</pub-id></mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simova</surname><given-names>I</given-names></name></person-group>. <article-title>Coronary Flow Velocity Reserve Assessment with Transthoracic Doppler Echocardiography.</article-title> <source>Eur Cardiol</source>. <year>2015</year> July;<volume>10</volume>(<issue>1</issue>):<fpage>12</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.15420/ecr.2015.10.01.12</pub-id><pub-id pub-id-type="pmid">30310417</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
